DKSH Technology Acquires Taqkey Science and Quantum Biotech, Two Technology Distribution Companies in Taiwan

Media release

DKSH has signed an agreement to acquire Taqkey Science (“Taqkey”) and Quantum Biotech (“Quantum”) in Taiwan. With these transactions, DKSH Technology further extends its scientific solutions and consumables businesses in line with the Business Units’ strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.

Zurich, Switzerland, March 18, 2025 – DKSH has announced today that it signed an agreement to acquire Taqkey and Quantum, two life science reagent and consumables distribution companies in Taiwan. The distributed products encompass reagents and consumables for molecular biology, genetic engineering, and cell-based therapies. Thus, DKSH Technology further anchors its regional presence in the life science industry in Asia-Pacific.

Founded in 2002, Taqkey is headquartered in Miaoli, Taiwan. Together with Quantum, the company employs more than 60 people and generates annual net sales of more than CHF 13 million¹ at good profitability and builds on successful, longstanding relationships with renowned blue-chip clients from the life science industry. The Group operates seven sales offices and three warehouses across Taiwan.

Hanno Elbraechter, Head Business Unit Technology at DKSH, said: “With Taqkey, we will further grow our consumables business in the life science industry of Asia-Pacific and thus solidify our position as a leading scientific solutions provider in the region. We are delighted to jointly leverage Taqkey’s attractive client and customer portfolio, and the synergies created by our joint operations.”

Jeffrey Cheung, Founder and Managing Director of Taqkey, commented: “We are excited about our shared future with DKSH, a leading technology solutions provider in Asia Pacific. As DKSH will benefit from our longstanding client and customer relationships in Taiwan, we will be happy to leverage DKSH’s broad expertise and to use existing sales channels to further grow our business. We are confident this step will positively impact all our business partners as well as our valued employees.”

The closing of the transaction is expected during the second quarter of 2025 and is subject to certain conditions.

¹ Exchange rate 1 Swiss Franc / 36.9 TWD

About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,820 specialists, the Business Unit generated net sales of CHF 549 million in 2024. www.dksh.com/tec  

For more information please contact:

DKSH Holding Ltd.

Till Leisner
Head, Group Investor & Media Relations
Phone +41 44 386 7315
till.leisner@dksh.com

Melanie Grüter
Manager Group Media Relations
Phone +41 44 386 7211
melanie.grueter@dksh.com